Close Menu

NEW YORK (GenomeWeb) – Scottish startup Natantis said today that it has been awarded £574,000 ($724,497) by the Scottish Enterprise's High Growth Spin-Out Program  to commercialize a device for the automated extraction of cell-free DNA (cfDNA) from blood.

Natantis — founded by researchers at Heriot-Watt University — has developed the CNAsafe device, which it says can extract cfDNA from whole blood in 45 minutes for use in liquid biopsy assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.